Dataset Information

Protein Lysine 43 Methylation by EZH1 Promotes AML1-ETO Transcriptional Repression

ABSTRACT: The MS data of Protein Lysine 43 Methylation by EZH1 Promotes AML1-ETO Transcriptional Repression Protein Lysine 43 Methylation by EZH1 Promotes AML1-ETO Transcriptional Repression

ORGANISM(S): Homo Sapiens

SUBMITTER: Shujun Liu

PROVIDER: PXD016712 | iProX | Wed Dec 11 00:00:00 GMT 2019

REPOSITORIES: iProX

ACCESS DATA

Publications

Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia.

Dou Liping L Yan Fei F Pang Jiuxia J Zheng Dehua D Li Dandan D Gao Li L Wang Lijun L Xu Yihan Y Shi Jinlong J Wang Qian Q Zhou Lei L Shen Na N Singh Puja P Wang Lili L Li Yonghui Y Gao Yvchi Y Liu Tao T Chen Chongjian C Al-Kali Aref A Litzow Mark R MR Chi Young-In YI Bode Ann M AM Liu Chunhui C Huang Haojie H Liu Daihong D Marcucci Guido G Liu Shujun S Yu Li L

Nature communications 20191107 1

The oncogenic fusion protein AML1-ETO retains the ability of AML1 to interact with the enhancer core DNA sequences, but blocks AML1-dependent transcription. Previous studies have shown that post-translational modification of AML1-ETO may play a role in its regulation. Here we report that AML1-ETO-positive patients, with high histone lysine methyltransferase Enhancer of zeste homolog 1 (EZH1) expression, show a worse overall survival than those with lower EZH1 expression. EZH1 knockdown impairs s ...[more]

PMID: 31699991

Similar Datasets

Project description:The covalent attachment of methyl groups to the side-chain of arginine residues is known to play essential roles in regulation of transcription, protein function and RNA metabolism. The specific N-methylation of arginine residues is catalyzed by a small family of gene products known as protein arginine methyltransferases; however, very little is known about which arginine residues become methylated on target substrates. Here we describe an unbiased methodology that combines single-step immunoenrichment of methylated peptides with high-resolution mass spectrometry to identify endogenous arginine mono-methylation (MMA) sites. We thereby identify 1,027 site-specific MMA sites on 494 human proteins, discovering numerous novel mono-methylation targets and confirming the majority of currently known MMA substrates. Nuclear RNA-binding proteins involved in RNA processing, RNA localization, transcription, and chromatin remodeling are prominently found modified with MMA. Despite this, MMA sites prominently are located outside RNA-binding domains as compared to the proteome-wide distribution of arginine residues. Quantification of arginine methylation in cells treated with Actinomycin D uncovers strong site-specific regulation of MMA sites during transcriptional arrest. Interestingly, several MMA sites are down-regulated after a few hours of under transcriptional arrest. In contrast, the corresponding di-methylation or protein expression level is not altered in expression, confirming that MMA sites contain regulated functions on their own. Collectively, we present a site-specific MMA dataset in human cells and demonstrate for the first time that MMA is a dynamic post-translational modification regulated during transcriptional arrest by a hitherto uncharacterized arginine demethylase. Data analysis: All raw data analysis was performed with MaxQuant software suite version 1.2.6.20 supported by the Andromeda search engine. Data was searched against a concatenated target/decoy (forward and reversed) version of the UniProtKB Human database encompassing 71,434 protein entries. Mass tolerance for searches was set to maximum 7 ppm for peptide masses and 20 ppm for HCD fragment ion masses. Data was searched with carbamidomethylation as a fixed modification and protein N-terminal acetylation, methionine oxidation and mono-methylation on lysine and arginine as variable modifications. A maximum of three mis-cleavages was allowed while requiring strict trypsin specificity, and only peptides with a minimum sequence length of seven were considered for further data analysis. Peptide assignments were statistically evaluated in a Bayesian model on the basis of sequence length and Andromeda score. Only peptides and proteins with a false discovery rate (FDR) of less than 1% were accepted, estimated on the basis of the number of accepted reverse hits. Protein sequences of common contaminants such as human keratins and proteases used were added to the database.

Dataset Information

Protein Lysine 43 Methylation by EZH1 Promotes AML1-ETO Transcriptional Repression

Publications

Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets